Company Profile

TopoGEN Inc
Profile last edited on: 9/14/21      CAGE: 49R06      UEI: NBL9ZBTWHV15

Business Identifier: Drug development and discovery involving topoisomerases
Year Founded
1991
First Award
1997
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

27960 County Road 319
Buena Vista, CO 81211
   (614) 451-5810
   info@topogen.com
   www.topogen.com
Location: Single
Congr. District: 05
County: Chaffee

Public Profile

TopoGEN is a research diagnostics company that works in drug development and discovery involving topoisomerases. The company provides Drug Screening Kits to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications. The company also provides assay kits for assaying both prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo. Furthermore, the company offers a complete line of DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $395,044
Project Title: A Peripheral Blood Biomarker for Alzheimer's Disease
2019 2 NIH $512,200
Project Title: Development of Nanoshield for Ambient Handling of Labile Bio-Products
2016 2 NIH $597,500
Project Title: Single Somatic Cell Epigenetic Models
2009 1 NIH $247,095
Project Title: Cell Based Screens For Topoisomerase Ii Targeting
2009 1 NIH $247,095
Project Title: Cell Based Screens for Topoisomerase Ii Targeting

Key People / Management

  Mark Muller -- CEO and Founder

  In Kwon Chung

  Bongyong Lee

  Gun E Lee

  Soren Muller -- President, Director of Operations

  Wanvipa Ruangpradit -- Technical Director

  Joseph H Spitzner

Company News

There are no news available.